Poor data delay Scottish needlesafety HTA (Health Technology Assessment)
This article was originally published in Clinica
The Health Technology Board for Scotland (HTBS) cannot proceed with plans to evaluate devices to prevent needlestick injuries, due to a lack of relevant data at national level. The HTBS is waiting for the results of an audit, involving all Scottish health boards and trusts, but does not yet have a time-line for the project, a spokesperson told Clinica.
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.